迈得医疗发布2025年度业绩快报，盈利0.653亿元

Core Viewpoint - The company, Maide Medical, is set to release its 2025 annual report, showing significant growth in net profit and revenue, indicating a strong operational performance and market demand for its products [1][2]. Financial Performance - In 2025, the company achieved an operating income of 447.42 million yuan, a year-on-year increase of 62.79% [2]. - The operating profit reached 59.70 million yuan, with a total profit of 61.22 million yuan, and a net profit attributable to the parent company of 65.26 million yuan, marking a substantial turnaround from losses [2][3]. - The net profit after deducting non-recurring gains and losses was 53.29 million yuan, reflecting significant improvement compared to the previous year [2]. Asset and Equity Growth - As of the end of the reporting period, total assets amounted to 1.19 billion yuan, up 12.69% from the previous year [2]. - The equity attributable to the parent company was 862.40 million yuan, an increase of 6.46% year-on-year [2]. - The net asset per share attributable to the parent company was 5.19 yuan, reflecting a 6.57% increase compared to the previous year [2]. Business Drivers - The substantial growth in operating income is attributed to the effective implementation of production plans, ensuring timely product delivery, and a dual focus on technological innovation and process iteration [2][3]. - The blood purification and medical device combination intelligent equipment sectors performed well, particularly due to strong market demand for medical consumables [2]. - The company is optimistic about the market demand for medical device combinations and is focusing on new product development and market expansion in this area [2].